Empowering maternal and newborn health research with Inovalon data

The journey of pregnancy and childbirth is complex and multifaceted, posing unique challenges and questions for healthcare providers, life sciences researchers, and public health agencies. In the U.S., the maternal mortality rate stands at over 32 deaths per 100,000 live births, signifying that American women face a risk of dying during pregnancy or within a year after childbirth that is, on average, 10 times greater than in other affluent, democratic countries. Understanding the nuances of this critical period requires comprehensive data and detailed analysis — resources that have traditionally been difficult to access and utilize effectively. Inovalon is revolutionizing this field with its Maternal-Newborn Health Linkage dataset, a powerful tool that is enhancing research and outcomes for mothers and infants across the United States.

The need for specialized data in maternal and newborn health

Research in maternal and newborn health is crucial. It enables a deep understanding of the impact of medications during pregnancy, shapes public health policies, and ensures the welfare of both mothers and their infants. By accessing comprehensive, linked data, healthcare professionals can extract significant insights that enhance care standards and improve health outcomes.

Inovalon’s role in maternal and newborn health research

Inovalon’s Maternal-Newborn Health Linkage dataset, which garnered the “Analytics Innovation of the Year” award in the 2023 BioTech Breakthrough Awards Program, stands as a critical resource in healthcare analytics. Sourced from over 160 U.S. healthcare payers, and linked at the subscriber identification level, it covers approximately 2 million expectant mothers and 2.5 million mother-baby pairs, providing a holistic mother-child journey from pre-pregnancy through childbirth and beyond.

How the dataset powers research

Inovalon’s dataset is not only vast, but also skillfully curated to offer comprehensive mother-child data linkages. It enables customers to:

• Gain in-depth insights: Unlock intricate patterns and identify key developments in maternal and child health
• Tailor for pregnancy studies: Track the healthcare journey of mothers and their infants, providing a longitudinal perspective
• Perform exhaustive analysis: Undertake retrospective and prospective examinations of more than a decade’s worth of data
• Maintain regulatory excellence Undertake HIPAA-compliant data analytics projects with confidence in the privacy and security of the information

Benefits and use cases

Inovalon’s Maternal-Newborn Health Linkage dataset empowers informed decision-making, fostering improved care across generations. Its multifaceted benefits are evident in various sectors:

• Life sciences and research: Conduct cohort studies and evaluating the effects of prenatal care on long-term outcomes
• Healthcare providers: Enhance the quality of care for expectant mothers and improve pediatric care coordination
• Public health agencies: Monitor high-risk pregnancies and births and inform policymaking to bolster maternal and child health

As we continue to navigate the complexities of maternal and newborn health, Inovalon’s dataset will undoubtedly play a critical role in shaping the future of healthcare through data-driven solutions.

Discover Inovalon real-world data to learn how Inovalon’s comprehensive and detailed analysis capabilities are paving the way for a healthier future.

Inovalon and design^® and Inovalon^® are trademarks of Inovalon, Inc.